Arrowstreet Capital, Limited Partnership Harmony Biosciences Holdings, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $136 Billion
- Q2 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 906,909 shares of HRMY stock, worth $29.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
906,909
Previous 398,411
127.63%
Holding current value
$29.5 Million
Previous $13.2 Million
116.73%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$215 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$53 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$51.4 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.92B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...